Intelligence Profile
Safety Profile
Safety Profile of Vibegron
Known Side Effects:
According to available evidence, common side effects of vibegron include headache, urinary tract infections, and nausea. Less common side effects may include diarrhea, dizziness, and palpitations.
Contraindications:
There isn’t extensive detailed information on specific contraindications for vibegron in the available evidence. Generally, patients with hypersensitivity to vibegron or any of its components should avoid this medication.
Drug Interactions:
The available data does not extensively outline specific drug interactions with vibegron. As with starting any new medication, it's essential to review the patient's full medication list with a healthcare provider.
Populations to Avoid Vibegron:
- Pediatric Use: Evidence for pediatric populations is limited, though studies are ongoing (NCT05491525). Usage should be considered with caution until more data is available.
- Elderly Populations: Although a real-world study investigated persistence in patients aged ≥ 80 (PMID: 41874710), the findings were primarily focused on persistence rather than detailed safety outcomes.
- Patients with Severe Renal or Hepatic Impairment: Caution is advised in these populations due to potential altered drug metabolism and clearance.
Evidence Gaps:
- Comprehensive long-term safety data is currently insufficient.
- Detailed profiles of contraindications and interactions need further clarity through completed clinical trials.
Disclaimer:
This summary is for informational purposes only and does not substitute professional medical advice. Consult a healthcare provider for personalized guidance.